1-(2-Fluorobenzyl)piperidine
|
- $437 - $2369
- Product name: 1-(2-Fluorobenzyl)piperidine
- CAS: 1426-74-0
- MF: C12H16FN
- MW: 193.26
- EINECS:
- MDL Number:MFCD06080710
- Synonyms:Piperidine, 1-[(2-fluorophenyl)methyl]-;1-(2-Fluorobenzyl)piperidine
5 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- Rieke Metals
Package
- 1g
- 5g
- ManufacturerChemenu
- Product numberCM503883
- Product description1-(2-Fluorobenzyl)piperidine 97%
- Packaging1g
- Price$437
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11259012
- Product description1-(2-Fluorobenzyl)piperidine 97%
- Packaging1g
- Price$437
- Updated2026-05-26
- Buy
- ManufacturerCrysdot
- Product numberCD11259012
- Product description1-(2-Fluorobenzyl)piperidine 97%
- Packaging5g
- Price$881
- Updated2026-05-26
- Buy
- ManufacturerRieke Metals
- Product numberNV00502
- Product description1-(2-FLUOROBENZYL)PIPERIDINE 97%GC-FID
- Packaging1g
- Price$986
- Updated2026-05-06
- Buy
- ManufacturerRieke Metals
- Product numberNV00502
- Product description1-(2-FLUOROBENZYL)PIPERIDINE 97%GC-FID
- Packaging5g
- Price$2369
- Updated2026-05-06
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM503883 | 1-(2-Fluorobenzyl)piperidine 97% | 1g | $437 | 2026-05-26 | Buy |
| Crysdot | CD11259012 | 1-(2-Fluorobenzyl)piperidine 97% | 1g | $437 | 2026-05-26 | Buy |
| Crysdot | CD11259012 | 1-(2-Fluorobenzyl)piperidine 97% | 5g | $881 | 2026-05-26 | Buy |
| Rieke Metals | NV00502 | 1-(2-FLUOROBENZYL)PIPERIDINE 97%GC-FID | 1g | $986 | 2026-05-06 | Buy |
| Rieke Metals | NV00502 | 1-(2-FLUOROBENZYL)PIPERIDINE 97%GC-FID | 5g | $2369 | 2026-05-06 | Buy |
Properties
Boiling point :121-123 °C(Press: 13 Torr)
Density :1.073±0.06 g/cm3(Predicted)
pka :8.39±0.10(Predicted)
Density :1.073±0.06 g/cm3(Predicted)
pka :8.39±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




